Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/10871
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorINCA-
dc.date.accessioned2022-10-04T14:22:56Z-
dc.date.available2022-10-04T14:22:56Z-
dc.date.issued2005-06-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/10871-
dc.subjectDependência de Morfinapt_BR
dc.subjectMorphine Dependencept_BR
dc.subjectDependencia de Morfinapt_BR
dc.subjectCuidados Paliativospt_BR
dc.subjectPalliative Carept_BR
dc.titleHC IV terá indicador sobre controle de uso da morfinapt_BR
dc.title.alternativeInforme INCA 198pt_BR
dc.TypeArticlept_BR
Appears in Collections:Informe INCA 198

Files in This Item:
File Description SizeFormat 
Informe-INCA-2005-198-4-HCIV-tera-indicador.pdf120.6 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.